CASafetyReporting object
Sponsor
National CA
CA(s) of EU&EFTA Member States concerned
SAE (Serious Adverse Event)
According to timelines specified in MEDDEV 2.7/3 December 2010
European standard SAE reporting form MEDDEV 2.7/3 to be used
Pre-market MD: Reporting of SAE/Incidents should be done according to the templates provided in Appendix (reporting form) of Meddev 2.7/3.
No
Not required, but the CA could require it in case of device without CE mark or used off-label.Not
Yes
Post market MDs (CE-marked use within label): Guidelines MEDDEV 2.12-2, rev.2 Jan 12. Reporting via the Medical Device Vigilance System
Pre market MDs: MEDDEV 2.7/3 December 2010 (serious adverse reporting)
Yes
The international standard ISO14155:2011 (Clinical investigation of medical devices for human subjects – Good Clinical Practice) applies to all clinical investigations of MD.
Combination studies (MD+MP): Reporting obligations follow the requirements for IMP studies.